University College London | Centre for Clinical Microbiology
Status and phase
Conditions
Treatments
About
This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
77 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Alterity Clinical Trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal